Draper has entered into a collaboration with Bristol-Myers Squibb to develop a unique liver tissue model for screening the toxicity of drugs. Draper will use its Human Organ Systems (HOS) platform—a microenvironment that can sustain human tissue organ models for several weeks of automated testing. Draper will array 96 independent single organ models in the high-throughput package in a version of its HOS platform named PREDICT-96. Using its platform, Draper will generate a unique liver model f...